193 related articles for article (PubMed ID: 30286109)
1. A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.
Nagamani S; Muthusamy K
PLoS One; 2018; 13(10):e0203194. PubMed ID: 30286109
[TBL] [Abstract][Full Text] [Related]
2. E-pharmacophore filtering and molecular dynamics simulation studies in the discovery of potent drug-like molecules for chronic kidney disease.
Nagamani S; Muthusamy K; Marshal JJ
J Biomol Struct Dyn; 2016 Oct; 34(10):2233-2250. PubMed ID: 26513595
[TBL] [Abstract][Full Text] [Related]
3. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.
Christakos S; Dhawan P; Verstuyf A; Verlinden L; Carmeliet G
Physiol Rev; 2016 Jan; 96(1):365-408. PubMed ID: 26681795
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of a Novel Vitamin D
Alshabrawy AK; Cui Y; Sylvester C; Yang D; Petito ES; Barratt KR; Sawyer RK; Heatlie JK; Polara R; Sykes MJ; Atkins GJ; Hickey SM; Wiese MD; Stringer AM; Liu Z; Anderson PH
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883516
[TBL] [Abstract][Full Text] [Related]
7. In silico identification and screening of CYP24A1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
Jayaraj JM; Krishnasamy G; Lee JK; Muthusamy K
J Biomol Struct Dyn; 2019 Apr; 37(7):1700-1714. PubMed ID: 29658431
[TBL] [Abstract][Full Text] [Related]
8. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
[TBL] [Abstract][Full Text] [Related]
9. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional insights on vitamin D receptor and CYP24A1 deleterious single nucleotide polymorphisms: A computational and pharmacogenomics perpetual approach.
Jayaraj JM; Kuriakose BB; Alhazmi AH; Muthusamy K
Cell Biochem Funct; 2021 Oct; 39(7):874-885. PubMed ID: 34231237
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
15. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
16. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
17. Structural aspects of Vitamin D endocrinology.
Rochel N; Molnár F
Mol Cell Endocrinol; 2017 Sep; 453():22-35. PubMed ID: 28257826
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation and synthesis of calcitroic acid.
Yu OB; Webb DA; Di Milo ES; Mutchie TR; Teske KA; Chen T; Lin W; Peluso-Iltis C; Rochel N; Helmstädter M; Merk D; Arnold LA
Bioorg Chem; 2021 Nov; 116():105310. PubMed ID: 34482171
[TBL] [Abstract][Full Text] [Related]
19. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
[TBL] [Abstract][Full Text] [Related]
20. Atom-based and Pharmacophore-based 3D - QSAR Studies on Vitamin D Receptor (VDR).
Nagamani S; Kesavan C; Muthusamy K
Comb Chem High Throughput Screen; 2018; 21(5):329-343. PubMed ID: 29874993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
